ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 45 filers reported holding ACORDA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $28,747,000 | -0.7% | 36,500,000 | +7.4% | 0.62% | +5.6% |
| Q2 2019 | $28,947,000 | +5.2% | 34,000,000 | +9.7% | 0.59% | -11.3% |
| Q1 2019 | $27,517,000 | +15.5% | 31,000,000 | +7.7% | 0.66% | +18.0% |
| Q4 2018 | $23,830,000 | -2.5% | 28,775,000 | 0.0% | 0.56% | +69.3% |
| Q3 2018 | $24,434,000 | -12.1% | 28,775,000 | 0.0% | 0.33% | +7.4% |
| Q2 2018 | $27,809,000 | +6.3% | 28,775,000 | 0.0% | 0.31% | +17.0% |
| Q1 2018 | $26,153,000 | +7.3% | 28,775,000 | 0.0% | 0.26% | -24.8% |
| Q4 2017 | $24,369,000 | -6.9% | 28,775,000 | -0.8% | 0.35% | -10.2% |
| Q3 2017 | $26,173,000 | +5.2% | 29,000,000 | 0.0% | 0.39% | -4.9% |
| Q2 2017 | $24,886,000 | +39.6% | 29,000,000 | +38.3% | 0.41% | -6.8% |
| Q1 2017 | $17,829,000 | – | 20,975,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
| PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
| Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
| Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
| CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
| PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
| Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |